Literature DB >> 2063944

Wheelchair cushions for persons with spinal cord injury: an update.

S L Garber1, L R Dyerly.   

Abstract

Occupational therapists frequently prescribe wheelchair cushions to reduce the risk of pressure sores in patients with spinal cord injury. In an earlier study (Garber, 1985b), Roho cushions were prescribed for the greatest number of subjects studied. The present study of 197 subjects updates these data and describes current prescription patterns, the use of cushions over time, satisfaction with prescribed cushions, and the occurrence of pressure sores with prescribed cushions. The study shows that the Jay cushion was prescribed most frequently for the current subjects, although it was not recommended for all persons with spinal cord injury. In the second phase of the present study, involving 30 subjects, 30% of the subjects discontinued use of the prescribed cushion. Skin breakdown and the discovery of alternative solutions were given as primary reasons. There was no significant difference in the incidence of pressure sores between subjects who continued to use their prescribed cushions and those who did not. This research supports the conclusion of earlier studies that no one wheelchair cushion is universally effective for all persons and that individual evaluation and routine reassessment are essential in reducing the occurrence of pressure sores.

Entities:  

Mesh:

Year:  1991        PMID: 2063944     DOI: 10.5014/ajot.45.6.550

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  2 in total

1.  Effects of conventional and alternating cushion weight-shifting in persons with spinal cord injury.

Authors:  Gary A Wu; Kath M Bogie
Journal:  J Rehabil Res Dev       Date:  2014

2.  Evaluation of pelvis postural systems in spinal cord injury patients: Outcome research.

Authors:  Serena Dattoli; Mariele Colucci; Maria Grazia Soave; Rita De Santis; Leandro Segaletti; Claudia Corsi; Marco Tofani; Donatella Valente; Giovanni Galeoto
Journal:  J Spinal Cord Med       Date:  2018-04-18       Impact factor: 1.985

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.